T Bschor

Summary

Affiliation: Technical University
Country: Germany

Publications

  1. doi request reprint Are bipolar disorders underdiagnosed in patients with depressive episodes? Results of the multicenter BRIDGE screening study in Germany
    T Bschor
    Schlosspark Clinic, Department of Psychiatry, Berlin, Germany Technical University of Dresden, University Hospital Dresden, Germany
    J Affect Disord 142:45-52. 2012
  2. doi request reprint Impact of citalopram on the HPA system. A study of the combined DEX/CRH test in 30 unipolar depressed patients
    Tom Bschor
    Schlosspark Clinic, Department of Psychiatry, Berlin, Germany
    J Psychiatr Res 46:111-7. 2012
  3. ncbi request reprint Association between response to lithium augmentation and the combined DEX/CRH test in major depressive disorder
    Tom Bschor
    Department of Psychiatry, Technische Universitat Dresden, Fetscherstrasse 74, D 01307, Dresden, Germany
    J Psychiatr Res 37:135-43. 2003
  4. pmc Hypothalamic-pituitary-thyroid system activity during lithium augmentation therapy in patients with unipolar major depression
    Tom Bschor
    Department of Psychiatry, Technische Universitat Dresden, Dresden, Germany
    J Psychiatry Neurosci 28:210-6. 2003
  5. ncbi request reprint Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression
    Tom Bschor
    Department of Psychiatry, Technische Universitat Dresden, Germany
    Depress Anxiety 17:43-8. 2003
  6. ncbi request reprint Lithium augmentation increases the ACTH and cortisol response in the combined DEX/CRH test in unipolar major depression
    Tom Bschor
    Department of Psychiatry, Technische Universitat Dresden, Dresden, Germany
    Neuropsychopharmacology 27:470-8. 2002
  7. ncbi request reprint Time experience and time judgment in major depression, mania and healthy subjects. A controlled study of 93 subjects
    T Bschor
    Department of Psychiatry, Technische Universitat Dresden, Dresden, Germany
    Acta Psychiatr Scand 109:222-9. 2004
  8. ncbi request reprint [Masked depression: the rise and fall of a diagnosis]
    Tom Bschor
    Klinik und Poliklinik für Psychiatrie und Psychotherapie der TU Dresden, Germany
    Psychiatr Prax 29:207-10. 2002
  9. doi request reprint No evidence for switching the antidepressant: systematic review and meta-analysis of RCTs of a common therapeutic strategy
    T Bschor
    Department of Psychiatry and Psychotherapy, Jewish Hospital of Berlin, Berlin, Germany
    Acta Psychiatr Scand 121:174-9. 2010
  10. pmc Lithium monotherapy increases ACTH and cortisol response in the DEX/CRH test in unipolar depressed subjects. A study with 30 treatment-naive patients
    Tom Bschor
    Department of Psychiatry, Schlosspark Clinic, Berlin, Germany
    PLoS ONE 6:e27613. 2011

Detail Information

Publications37

  1. doi request reprint Are bipolar disorders underdiagnosed in patients with depressive episodes? Results of the multicenter BRIDGE screening study in Germany
    T Bschor
    Schlosspark Clinic, Department of Psychiatry, Berlin, Germany Technical University of Dresden, University Hospital Dresden, Germany
    J Affect Disord 142:45-52. 2012
    ....
  2. doi request reprint Impact of citalopram on the HPA system. A study of the combined DEX/CRH test in 30 unipolar depressed patients
    Tom Bschor
    Schlosspark Clinic, Department of Psychiatry, Berlin, Germany
    J Psychiatr Res 46:111-7. 2012
    ..However, studies on the influence of treatment on the HPA system have partly yielded inconsistent results...
  3. ncbi request reprint Association between response to lithium augmentation and the combined DEX/CRH test in major depressive disorder
    Tom Bschor
    Department of Psychiatry, Technische Universitat Dresden, Fetscherstrasse 74, D 01307, Dresden, Germany
    J Psychiatr Res 37:135-43. 2003
    ..Results of this study should be confirmed in a larger study group...
  4. pmc Hypothalamic-pituitary-thyroid system activity during lithium augmentation therapy in patients with unipolar major depression
    Tom Bschor
    Department of Psychiatry, Technische Universitat Dresden, Dresden, Germany
    J Psychiatry Neurosci 28:210-6. 2003
    ..This study aimed at exploring the role of thyroid function in lithium augmentation and used a prospective design that included a homogeneous sample of inpatients with unipolar major depressive disorder...
  5. ncbi request reprint Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression
    Tom Bschor
    Department of Psychiatry, Technische Universitat Dresden, Germany
    Depress Anxiety 17:43-8. 2003
    ..This is in contrast to the established decline of HPA system activity during treatment with tricyclic antidepressants...
  6. ncbi request reprint Lithium augmentation increases the ACTH and cortisol response in the combined DEX/CRH test in unipolar major depression
    Tom Bschor
    Department of Psychiatry, Technische Universitat Dresden, Dresden, Germany
    Neuropsychopharmacology 27:470-8. 2002
    ..This effect might be explained by the serotonergic effects of lithium...
  7. ncbi request reprint Time experience and time judgment in major depression, mania and healthy subjects. A controlled study of 93 subjects
    T Bschor
    Department of Psychiatry, Technische Universitat Dresden, Dresden, Germany
    Acta Psychiatr Scand 109:222-9. 2004
    ..Studies on the time sense of depressed patients have revealed inconsistent results. Manic patients have been almost neglected...
  8. ncbi request reprint [Masked depression: the rise and fall of a diagnosis]
    Tom Bschor
    Klinik und Poliklinik für Psychiatrie und Psychotherapie der TU Dresden, Germany
    Psychiatr Prax 29:207-10. 2002
    ..Today this diagnosis does not play an important role any more - neither clinically nor scientifically. This article examines the background of the enormous initial importance of this diagnostic concept and of its final abandonment...
  9. doi request reprint No evidence for switching the antidepressant: systematic review and meta-analysis of RCTs of a common therapeutic strategy
    T Bschor
    Department of Psychiatry and Psychotherapy, Jewish Hospital of Berlin, Berlin, Germany
    Acta Psychiatr Scand 121:174-9. 2010
    ..Switching antidepressants is a common strategy for managing treatment-resistant depressed patients. However, no systematic reviews have been conducted to date...
  10. pmc Lithium monotherapy increases ACTH and cortisol response in the DEX/CRH test in unipolar depressed subjects. A study with 30 treatment-naive patients
    Tom Bschor
    Department of Psychiatry, Schlosspark Clinic, Berlin, Germany
    PLoS ONE 6:e27613. 2011
    ..Lithium is central to the treatment of affective disorders, but little is known about its effects on the HPA system of depressed subjects...
  11. ncbi request reprint Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms
    T Bschor
    Department of Psychiatry and Psychotherapy, Technische Universitat Dresden, Dresden, Germany
    Pharmacopsychiatry 36:S230-4. 2003
    ..Here we review new data on the efficacy and mechanism of action of lithium augmentation...
  12. ncbi request reprint Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression
    M Adli
    Department of Psychiatry and Psychotherapy, Charite Universitatsmedizin Berlin, Campus Charite Mitte, Berlin, Germany
    Pharmacopsychiatry 41:252-7. 2008
    ..Because the irreversible monoamine oxidase inhibitor tranylcypromine (TCP) was introduced nearly 50 years ago, only few studies exist on today's clinical prescribing practice together with 2nd and 3rd generation psychotropic drugs...
  13. ncbi request reprint Predictors of response to lithium augmentation in tricyclic antidepressant-resistant depression
    T Bschor
    Department of Psychiatry, Freie Universitat Berlin, Berlin, Germany
    J Affect Disord 64:261-5. 2001
    ..The efficacy of lithium augmentation in therapy-resistant depression has been shown in a series of well-designed, placebo-controlled studies. However, little is known about the predictors of a good response to this treatment strategy...
  14. doi request reprint No correlation between lithium serum levels and psychopathological features during the euthymic interval of patients with recurrent affective disorder
    U Lewitzka
    Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Dresden, Germany
    Pharmacopsychiatry 45:1-6. 2012
    ..The aim of this prospective study was to investigate the influence of lithium serum levels on subclinical psychopathological features during the euthymic interval in patients with an affective disorder...
  15. ncbi request reprint Do antidepressants influence mood patterns? A naturalistic study in bipolar disorder
    M Bauer
    Department of Psychiatry and Psychotherapy, Charite University Medicine Berlin, Campus Charité Mitte CCM, Schumannstrasse 20 21, 10117 Berlin, Germany
    Eur Psychiatry 21:262-9. 2006
    ..Antidepressants had little impact on the mood patterns of bipolar patients taking mood stabilizers...
  16. ncbi request reprint Comparing augmentation with non-antidepressants over sticking to antidepressants after treatment failure in depression: a naturalistic study
    S Kohler
    Department of Psychiatry, Charite University Medicine Berlin, Campus Mitte, Berlin, Germany
    Pharmacopsychiatry 46:69-76. 2013
    ..However, there is a lack of direct comparisons of these different strategies. In this naturalistic study we compared the outcome to different strategies after failure of the primary antidepressant treatment...
  17. ncbi request reprint Subjective response to and tolerability of long-term supraphysiological doses of levothyroxine in refractory mood disorders
    M Bauer
    Department of Psychiatry, Klinikum Benjamin Franklin, Freie Universitat Berlin, Berlin, Germany
    J Affect Disord 64:35-42. 2001
    ..This is the first study to investigate subjective patient response and tolerability to long-term treatment with adjunctive T4...
  18. ncbi request reprint The challenge of treatment in bipolar depression: evidence from clinical guidelines, treatment recommendations and complex treatment situations
    S Kohler
    Department of Psychiatry and Psychotherapy, Charite University Medicine Berlin, Campus Mitte, Berlin, Germany
    Pharmacopsychiatry 47:53-9. 2014
    ..Furthermore, alternative pharmacological treatment strategies and complex treatment situations are discussed. ..
  19. ncbi request reprint Decreased level of EEG-vigilance in acute mania as a possible predictor for a rapid effect of methylphenidate: a case study
    T Bschor
    Berlin Lithium Clinic, Berlin, Germany
    Clin Electroencephalogr 32:36-9. 2001
    ..Patient A (with a decreased EVL) responded rapidly to methylphenidate with a considerable reduction of symptoms and a clear increase of EVL, whereas patient B (normal EVL) did not show any change, neither clinically nor in the EEG...
  20. ncbi request reprint Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients
    Christopher Baethge
    Department of Psychiatry, Harvard Medical School, McLean Division of Massachusetts General Hospital, Belmont, MA 02478, USA
    J Clin Psychiatry 66:174-82. 2005
    ..These trials suggest added benefit of combination treatment over use of either agent alone but also indicate the need for further studies...
  21. ncbi request reprint How long should the lithium augmentation strategy be maintained? A 1-year follow-up of a placebo-controlled study in unipolar refractory major depression
    Tom Bschor
    Department of Psychiatry, Technische Universitat Dresden, Dresden, Germany
    J Clin Psychopharmacol 22:427-30. 2002
    ..Study data suggest that active medication should be maintained for at least 1 year after successful lithium augmentation in patients with unipolar major depressive disorder...
  22. ncbi request reprint Lithium augmentation therapy in refractory depression-update 2002
    Michael Bauer
    Klinik fur Psychiatrie und Psychotherapie, Charite Campus Mitte Humboldt Universitat zu Berlin, Schumannstr 20 21, 10117, Berlin, Germany
    Eur Arch Psychiatry Clin Neurosci 253:132-9. 2003
    ..Therefore, it should be considered a first-line treatment strategy in patients with major depression who do not adequately respond to standard antidepressants...
  23. ncbi request reprint Lithium augmentation therapy in refractory depression: clinical evidence and neurobiological mechanisms
    Michael Bauer
    Department of Psychiatry and Psychotherapy, Charite University Hospital, Humboldt University at Berlin, Schumannstr 20 21, 10117 Berlin, Germany
    Can J Psychiatry 48:440-8. 2003
    ..It also examines hypotheses on the mode of action of lithium augmentation, with a focus on serotonin (5-HT) and neuroendocrine systems, and proposes recommendations for future research...
  24. ncbi request reprint Prophylaxis latency and outcome in bipolar disorders
    Christopher Baethge
    Consolidated Department of Psychiatry, Harvard Medical School, Bipolar and Psychotic Disorders Program, McLean Division of Massachusetts General Hospital, Belmont, Massachusetts, USA
    Can J Psychiatry 48:449-57. 2003
    ..To analyze new and reviewed findings to evaluate relations between treatment response and latency from onset of bipolar disorder (BD) to the start of mood-stabilizer prophylaxis...
  25. pmc Effectiveness and outcome predictors of long-term lithium prophylaxis in unipolar major depressive disorder
    Christopher Baethge
    Consolidated Department of Psychiatry, Harvard Medical School, The Bipolar and Psychotic Disorders Program, McLean Division of Massachusetts General Hospital, Belmont, Mass 02478 9106, USA
    J Psychiatry Neurosci 28:355-61. 2003
    ..To determine the effectiveness of lithium prophylaxis in unipolar major depressive disorder (MDD) and to identify predictors of outcome including comedication...
  26. doi request reprint Self-reporting software for bipolar disorder: validation of ChronoRecord by patients with mania
    Michael Bauer
    Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universitat Dresden, Fetscherstr 74, 01307 Dresden, Germany
    Psychiatry Res 159:359-66. 2008
    ..Post-hoc analysis of the level of agreement between ChronoRecord and YMRS ratings was excellent or good in all cases using the kappa statistic. These data demonstrate concurrent validity between ChronoRecord and YMRS...
  27. ncbi request reprint Bone mineral density during maintenance treatment with supraphysiological doses of levothyroxine in affective disorders: a longitudinal study
    Michael Bauer
    Department of Psychiatry and Psychotherapy, Charite University Medicine Berlin, Campus Charite Mitte, Berlin, Germany
    J Affect Disord 83:183-90. 2004
    ....
  28. ncbi request reprint Temporal relation between sleep and mood in patients with bipolar disorder
    Michael Bauer
    Department of Psychiatry and Psychotherapy, Charite University Medicine Berlin, Campus Charité Mitte CCM, Berlin, Germany
    Bipolar Disord 8:160-7. 2006
    ..Sleep disturbances are frequent warning signs of both mania and depression. This study used cross correlation analysis to characterize the relationship between mood, sleep and bedrest in longitudinal data...
  29. ncbi request reprint Is successful lithium augmentation limited to serotonergic antidepressants?
    Tom Bschor
    J Clin Psychopharmacol 24:240-1; author reply 241-2. 2004
  30. ncbi request reprint Efficacy and mechanisms of action of lithium augmentation in refractory major depression
    Tom Bschor
    Department of Psychiatry and Psychotherapy, Jewish Hospital Berlin, Heinz Galinski Str 1, D 13347 Berlin, Germany
    Curr Pharm Des 12:2985-92. 2006
    ..In international treatment guidelines and algorithms, lithium augmentation is considered a first-line treatment strategy for patients with a major depressive episode who do not adequately respond to standard antidepressant treatment...
  31. ncbi request reprint Using ultrasonography to determine thyroid size and prevalence of goiter in lithium-treated patients with affective disorders
    Michael Bauer
    Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universitat Dresden, Dresden, Germany
    J Affect Disord 104:45-51. 2007
    ..To determine thyroid gland volume and the prevalence of goiter in patients receiving long-term lithium treatment for affective disorders...
  32. ncbi request reprint Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up
    Christopher Baethge
    Department of Psychiatry and Psychotherapy, Universitatsklinikum Benjamin Franklin, Freie Universitat Berlin, Eschenallee 3, 14050 Berlin, Germany
    J Affect Disord 79:43-50. 2004
    ....
  33. ncbi request reprint World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care
    Michael Bauer
    University Hospital Carl Gustav Carus, Department of Psychiatry and Psychotherapy, Technische Universitat Dresden, Dresden, Germany
    World J Biol Psychiatry 8:67-104. 2007
    ..They deal primarily with biological treatment (including antidepressants, other psychopharmacological and hormonal medications, electroconvulsive therapy, light therapy)...
  34. pmc Long-term lithium treatment and thyroid antibodies: a controlled study
    Christopher Baethge
    Department of Psychiatry, Bipolar and Psychotic Disorders Program, Harvard Medical School, McLean Division of Massachusetts General Hospital, Belmont, Mass, USA
    J Psychiatry Neurosci 30:423-7. 2005
    ....
  35. ncbi request reprint Supraphysiological doses of L-thyroxine in the maintenance treatment of prophylaxis-resistant affective disorders
    Michael Bauer
    Department of Psychiatry and Psychotherapy, Charite, Humboldt University of Berlin, Berlin, Germany
    Neuropsychopharmacology 27:620-8. 2002
    ..In conclusion, adjunctive treatment with L-thyroxine in supraphysiological doses may be an effective strategy in the maintenance treatment of patients with prophylaxis-resistant affective disorders...
  36. ncbi request reprint Hallucinations in bipolar disorder: characteristics and comparison to unipolar depression and schizophrenia
    Christopher Baethge
    Department of Psychiatry, International Consortium for Bipolar Disorder Research, Harvard Medical School, McLean Division of Massachusetts General Hospital, Belmont, MA 02478 9106, USA
    Bipolar Disord 7:136-45. 2005
    ..As there is very little research on the topic, we compared the frequency and the type hallucinations among hospitalized patients diagnosed with bipolar disorder (BPD) versus other major psychiatric illnesses...
  37. ncbi request reprint [Alterations of time judgement with age]
    Richard Mahlberg
    Psychiatrische Universitätsklinik der Charité im St Hedwig Krankenhaus Berlin, Germany
    Psychiatr Prax 34:117-21. 2007
    ..Although there have been frequent reports of changes in these two processes with increasing age, none of these changes has been demonstrated using objective measures...